In development: Guidance, quality standards and advice
Showing 11 to 20 of 30
| Title | Type | Expected publication date |
|---|---|---|
| Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age ID6484 | Highly specialised technology | TBC |
| Ectopic pregnancy and miscarriage: diagnosis and initial management (update) | NICE guideline | TBC |
| Familial Breast Cancer: initial assessment and genetic testing (update) | NICE guideline | |
| Fertility problems: assessment and treatment - update 1 and 2 | NICE guideline | TBC |
| Kidney Cancer | NICE guideline | |
| Mental health guidelines | NICE guideline | TBC |
| Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | NICE guideline | TBC |
| Obsessive-compulsive disorder and body dysmorphic disorder: assessment and management | NICE guideline | TBC |
| Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update) | NICE guideline | TBC |
| Pegzilarginase for treating arginase-1 deficiency [ID4029] | Highly specialised technology | TBC |